Your session is about to expire
← Back to Search
Shockwave Therapy
Shockwave Therapy for Plantar Fasciitis
N/A
Waitlist Available
Led By Kristina Quirolgico, MD
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Minimum VAS pain of 40/100 (4/10; morning pain when taking first steps, pain after prolonged walking/standing)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
Study Summary
This trial sought to compare the effect of radial vs. focused extracorporeal shockwave therapy on pain in patients with chronic plantar fasciitis.
Who is the study for?
This trial is for English-speaking individuals with chronic plantar fasciitis, experiencing significant morning pain or discomfort after long periods of standing/walking. They should have had the condition for over 3 months and found other treatments ineffective. People with recent platelet-rich plasma injections, infections, rheumatologic or systemic inflammatory disorders, bone diseases in the lower extremity, coagulopathies, calcaneal fractures, nerve issues, tendon ruptures or previous foot surgery are excluded.Check my eligibility
What is being tested?
The study is testing two types of shockwave therapy—radial and focused—to see which one better reduces pain from chronic plantar fasciitis compared to home therapy. It's a randomized controlled trial (RCT), meaning participants will be randomly assigned to receive either radial shockwave therapy, focused shockwave therapy or continue with their home therapy regimen.See study design
What are the potential side effects?
Shockwave therapies may cause temporary side effects such as bruising, swelling at the treatment site, pain during and after treatment sessions and possibly skin damage if not administered correctly.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My pain level is at least 4 out of 10 when I walk or stand for a long time.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Visual analog scale pain - after prolonged walking or standing
Visual analog scale pain - morning
Secondary outcome measures
Foot and Ankle Outcome Score (FAOS)
PROMIS Physical Function computer adaptive test score
Treatment satisfaction
Trial Design
3Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Patients in the control group will be treated using the home therapy protocol only.
Group II: Radial shockwave therapyActive Control3 Interventions
Patients will receive 4 sessions of radial shockwave therapy.
Group III: Focused shockwave therapyActive Control3 Interventions
Patients will receive 4 sessions of focused shockwave therapy.
Find a Location
Who is running the clinical trial?
Hospital for Special Surgery, New YorkLead Sponsor
243 Previous Clinical Trials
59,250 Total Patients Enrolled
Kristina Quirolgico, MDPrincipal InvestigatorHospital for Special Surgery, New York
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a condition that causes long-term inflammation in my body.I have a trapped nerve.I have had a tendon rupture.I have pain in both of my heels.I have not had a cortisone injection in the last 3 months.I have a bleeding disorder or I'm taking blood thinners.My pain level is at least 4 out of 10 when I walk or stand for a long time.I have issues with my nerves or blood vessels.I have an ongoing infection in the area.I have a bone disorder in my legs.I have not had a platelet-rich plasma injection in the last 6 months.I have a heel bone fracture.I have a disorder affecting my joints, muscles, or connective tissues.I have had surgery on my foot before.I have had chronic plantar fasciitis for over 3 months that hasn't improved with treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Radial shockwave therapy
- Group 3: Focused shockwave therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who is eligible to be a participant in this clinical experimentation?
"This trial is recruiting 114 adults aged 18 to 100 who are suffering from plantar fasciitis. Patients need to have a minimum VAS pain of 40/100 (4/10) and must present with chronic symptoms that have not responded to other treatments."
Answered by AI
Is the age criterion for inclusion in this trial limited to those 18 years of age or older?
"As indicated in the eligibility requirements, individuals between 18 to 100 years old can partake in this medical trial."
Answered by AI
What is the patient population size for this experimental treatment?
"Confirmed. Clinicaltrials.gov documents this medical trial's commencement on June 1st, 2020 and its most recent update occurring September 8th 2022. The research is actively seeking 114 individuals to be enrolled across one site."
Answered by AI
Is enrolment still available for this research trial?
"Clinicaltrials.gov affirms that the trial is still recruiting test subjects, which began on June 1st 2020 and was recently updated September 8th 2022."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger